Neovascular glaucoma treated by intravitreal triamcinolone acetonide [2]

Acta Ophthalmologica Scandinavica

Volumn 81, Issue 5, 2003, Pages 540-541

  Jonas, Jost B ^a,b,c   Kreissig, Ingrid ^a,b   Degenring, Robert F ^a,b  

^a Eye Hospital   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE ACETONIDE;

AGED; ANTERIOR EYE CHAMBER; ARGON LASER; CASE REPORT; DIABETIC RETINOPATHY; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; GONIOSCOPY; HUMAN; INFORMED CONSENT; INTRAOCULAR PRESSURE; LETTER; NEOVASCULAR GLAUCOMA; NEOVASCULARIZATION (PATHOLOGY); PHACOEMULSIFICATION; PRIORITY JOURNAL; RETINA MACULA DEGENERATION; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; VISUAL ACUITY;

EID: 0142061608     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.2003.00130.x     Document Type: Letter

References (8)

1. Antoszyk AN, Gottlieb JL, Machemer R & Hatchell DL (1993): The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization. Graefes Arch Clin Exp Ophthalmol 231: 34-40.
2. Bandello F, Brancato R, Lattanzio R, Falcomata B & Malegori A (1993): Biomicroscopy versus fluorescein angiography of the iris in the detection of diabetic iridopathy. Graefes Arch Clin Exp Ophthalmol 231: 444-448.
3. Danis RP, Bingaman DP, Yang Y & Ladd B (1996): Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide. Ophthalmology 103: 2099-2104.
4. Gillies MC, Simpson JM, Luo W, Penfold P, Hunyor AB, Chua W, Mitchell P & Billson F (2003): A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: 1-year results. Arch Ophthalmol 121: 667-673.
5. Jonas JB, Hayler JK, Söfker A & Panda-Jonas S (2001): Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone. J Glaucoma 10: 284-287.
6. Machemer R, Sugita G & Tano Y (1979): Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc 77: 171-180.
7. Sivak-Callcott JA, O'Day DM, Gass JDM & Tsai JC (2001): Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology 108: 1767-1776.
8. Tano Y, Sugita G, Abrams G & Machemer R (1980): Inhibition of intraocular proliferation with intravitreal corticosteroid. Am J Ophthalmol 89: 131-136.